Cargando…
Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study
Autores principales: | Machida, Hiroko, Matsuo, Koji, Enomoto, Takayuki, Mikami, Mikio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779622/ https://www.ncbi.nlm.nih.gov/pubmed/31576698 http://dx.doi.org/10.3802/jgo.2019.30.e113 |
Ejemplares similares
-
Impact of adjuvant chemotherapy on the overall survival of patients with resectable bulky small cell neuroendocrine cervical cancer: a JSGO-JSOG joint study
por: Seino, Manabu, et al.
Publicado: (2022) -
Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study
por: Machida, Hiroko, et al.
Publicado: (2021) -
Impact of lymphadenectomy on the treatment of endometrial cancer using data from the JSOG cancer registry
por: Saotome, Keiko, et al.
Publicado: (2021) -
Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer
por: Matsuo, Koji, et al.
Publicado: (2019) -
Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
por: Kobayashi, Yusuke, et al.
Publicado: (2022)